Chloroquine and Hydroxychloroquine – drugs used against malaria – have raised significant controversy. Data on treatment or prophylaxis for COVID-19 is limited. Some studies have shown that these drugs may be helpful, others caution about serious side effects. This Webinar will discuss the role of randomized controlled clinical trials in developing safe and effective medications for treatment and prophylaxis of COVID-19.
Date: May 13, 8:00 AM (EST)
Click HERE to see the live recording!
Isabelle Niu, MA, Journalist at Quartz based in New York
NOTE: This webinar will not offer continuing education credits
- Outline the justifications for randomized controlled trials for COVID-19
- Outline ethical issues around clinical trials in pandemics
- Provide resources for ongoing clinical trials on the use of Chloroquine, Hydroxychloroquine and other drugs for treatment and prevention of COVID-19